https://bioinformatics.umg.eu/onkopus/drugon#l04immunosuppressants

Properties

label
[] l04 immunosuppressants

Parents

Children

Relations

is_atc
dimethylfumarate
is_atc
abatacept
is_atc
secukinumab
is_atc
alefacept
is_atc
guselkumab
is_atc
deucravacitinib
is_atc
antilymphocyteimmunoglobulinhorse
is_atc
afelimomab
is_atc
sirukumab
is_atc
lenalidomide
is_atc
etanercept
is_atc
anakinra
is_atc
fingolimod
is_atc
siponimod
is_atc
begelomab
is_atc
ozanimod
is_atc
belimumab
is_atc
tildrakizumab
is_atc
teriflunomide
is_atc
muromonab
is_atc
siltuximab
is_atc
voclosporin
is_atc
leflunomide
is_atc
infliximab
is_atc
risankizumab
is_atc
upadacitinib
is_atc
brodalumab
is_atc
sarilumab
is_atc
emapalumab
is_atc
gusperimus
is_atc
natalizumab
is_atc
thalidomide
is_atc
filgotinib
is_atc
imlifidase
is_atc
ravulizumab
is_atc
satralizumab
is_atc
briakinumab
is_atc
ustekinumab
is_atc
ixekizumab
is_atc
certolizumabpegol
is_atc
alemtuzumab
is_atc
darvadstrocel
is_atc
anifrolumab
is_atc
eculizumab
is_atc
ocrelizumab
is_atc
tacrolimus
is_atc
golimumab
is_atc
inebilizumab
is_atc
azathioprine
is_atc
vedolizumab
is_atc
belatacept
is_atc
diroximelfumarate
is_atc
spesolimab
is_atc
abetimus
is_atc
cladribine
is_atc
everolimus
is_atc
basiliximab
is_atc
apremilast
is_atc
tocilizumab
is_atc
adalimumab
is_atc
canakinumab
is_atc
ofatumumab
is_atc
baricitinib
is_atc
bimekizumab
is_atc
teprotumumab
is_atc
methotrexate
is_atc
sutimlimab
is_atc
efalizumab
is_atc
antithymocyteimmunoglobulinrabbit
is_atc
belumosudil
is_atc
ponesimod
is_atc
pegcetacoplan
is_atc
sirolimus
is_atc
tofacitinib
is_atc
peficitinib
is_atc
pomalidomide
is_atc
pirfenidone
is_atc
daclizumab
is_atc
mycophenolicacid
is_atc
cyclosporine
is_atc
itacitinib
is_atc
rilonacept